DEA Controlled Substance API manufacturing

Posted: March 19, 2018

API Manufacturing and Pharmaceutical Manufacturing

Ed Price, President/Chief Executive Officer talks about Controlled Substance API Manufacturing at PCI Synthesis.

Related posts:

PCI Synthesis obtains DEA registration for controlled substance development and manufacturing
PCI Synthesis at DCAT Week 2017
PCI Synthesis - API Manufacturing Capabilities
5 Attributes to look for in a CMO's Technical R&D Team
5 Points to Consider when Evaluating your CMO's Analytical Capabilities

About the Author

Ed Price CEO of PCI Synthesis
Ed is the President and CEO of PCI Synthesis (PCI), he serves as a co-chair of the New England CRO/CMO Council and sits on the Industrial Advisory Board for the Department of Chemical Engineering at UMass, Amherst. Ed is also a long standing member of the American Chemical Society and advises the Bulk Pharmaceutical Task Force of the Society of Chemical Manufacturer’s and Affiliates (SOCMA).

Do you have questions? Talk to Ed.